Examination of a biliodigestive anastomosis presents a diagnostic and therapeutic challenge. Visualization of biliodigestive anastomosis and endoscopic retrograde cholangiography with intervention is possible with a double balloon enteroscope.

1.
Tashiro H, Itamoto T, Sasaki T, Ohdan H, Fudaba Y, Amano H, Fukuda S, Nakahara H, Ishiyama K, Ohshita A, Kohashi T, Mitsuta H, Chayama K, Asahara T: Biliary complications after duct-to-duct biliary reconstruction in living-donor liver transplantation: causes and treatment. World J Surg 2007;31:2222–2229.
2.
Holt AP, Thorburn D, Mirza D, Gunson B, Wong T, Haydon G: A prospective study of standardized nonsurgical therapy in the management of biliary anastomotic strictures complicating liver transplantation. Transplantation 2007;84:857–863.
3.
Solmi L, Cariani G, Leo P, Miracolo A, Nigro G, Roda E: Results of endoscopic retrograde cholangiopancreatography in the treatment of biliary tract complications after orthotopic liver transplantation: our experience. Hepatogastroenterology 2007;54:1004–1008.
4.
Park JS, Kim MH, Lee SK, Seo DW, Lee SS, Han J, Min YI, Hwang S, Park KM, Lee YJ, Lee SG, Sung KB: Efficacy of endoscopic and percutaneous treatments for biliary complications after cadaveric and living donor liver transplantation. Gastrointest Endosc 2003;57:78–85.
5.
Polese L, Cillo U, Brolese A, Boccagni P, Neri D, Bassi D, Erroi F, Zanus G, D’Amico DF, Norberto L: Endoscopic treatment of bile duct complications after orthotopic liver transplantation. Transplant Proc 2007;39:1942–1944.
6.
Christensen M, Matzen P, Schulze S, Rosenberg J: Complications of ERCP: a prospective study. Gastrointest Endosc 2004;60:721–731.
7.
Cheng CL, Sherman S, Watkins JL, Barnett J, Freeman M, Geenen J, Ryan M, Parker H, Frakes JT, Fogel EL, Silverman WB, Dua KS, Aliperti G, Yakshe P, Uzer M, Jones W, Goff J, Lazzell-Pannell L, Rashdan A, Temkit M, Lehman GA: Risk factors for post-ERCP pancreatitis: a prospective multicenter study. Am J Gastroenterol 2006;101:139–147.
8.
Valera-Sanchez Z, Flores-Cortes M, Romero-Vargas ME, Gómez-Bravo MA, Pareja-Ciuró F, Lopez-Bernal F, Barrera-Pulido A, Bermejo-Navas J, García-González I, Bernardos-Rodriguez A: Biliodigestive anastomosis in liver transplantation: review of 13 years. Transplant Proc 2006;38:2471–2472.
9.
Oh HC, Lee SK, Lee TY, Kwon S, Lee SS, Seo DW, Kim MH: Analysis of percutaneous transhepatic cholangioscopy-related complications and the risk factors for those complications. Endoscopy 2007;39:731–736.
10.
Sung RS, Campbell DA Jr, Rudich SM, Punch JD, Shieck VL, Armstrong JM, Ford E, Sullivan P, Dasika NL, Magee JC: Long-term follow-up of percutaneous transhepatic balloon cholangioplasty in the management of biliary strictures after liver transplantation. Transplantation 2004;77:110–115.
11.
Chahal P, Baron TH, Poterucha JJ, Rosen CB: Endoscopic retrograde cholangiography in post-orthotopic liver transplant population with Roux-en-Y biliary reconstruction. Liver Transpl 2007;13:1168–1173.
12.
Haruta H, Yamamoto H, Mizuta K, Kita Y, Uno T, Egami S, Hishikawa S, Sugano K, Kawarasaki H: A case of successful enteroscopic balloon dilation for late anastomotic stricture of choledochojejunostomy after living donor liver transplantation. Liver Transpl 2005;11:1608–1610.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.